Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
This same principle applies when comparing semaglutide, tirzepatide, and future medications such as retatrutide
FDA enforcement actions, shortage list removals, and evolving state licensing rules mean that what was true about Red Rock six months ago may not apply today
May contribute to greater vitality and day-to-day performance
76 Additionally, excessive GSH may alter bacterial intracellular redox homeostasis, which paradoxically leads to increased production of ROS and causes oxidative damage
Ost, L., Wettrell, G., Bjrkhem, I., & Rane, A